Join Tom and Mike as they share an important update on Tom's prostate cancer journey. In this video, they discuss Tom's ...

Radiopharmaceutical therapy (RPT) combined with external beam radiotherapy (EBRT) is emerging as a powerful approach in prostate cancer treatment. Historically rooted in early 89Sr trials, this ...

Model was developed from the prostate cancer screening group of the PLCO and validated externally in a VA population ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.

University of Michigan researchers have developed a model that can help doctors and patients understand their PSA results and what they mean for patient life expectancy.

A former prostate cancer patient who got the all-clear said taking part in a trial that cut his radiotherapy treatments ...

Study results are based on Surveillance, Epidemiology, and End Results-Medicare data for 166,581 patients receiving surgery or radiation for localized prostate cancer.

Xtandi, Astellas’ roughly $6 billion prostate cancer juggernaut by annual sales, is set to lose U.S. patent protection in ...

Whether you're a patient, caregiver, clinician or simply looking to learn more, this guide is FREE to download below: Somatic ...

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...